NDC00067-0300-82: THEOPHYLLINE EXTENDED-RELEASE CA.
THEOPHYLLINE EXTENDED-RELEASE CA. Key specifications include special_features: ANHYDROUS, primary_container_type: BOTTLE, therapeutic_equivalent: SLO-BID BY RORER PHARMACEUTICALS, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, active_medicament_medicinal_strength: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT, capsule_primary_container_content_quantity: 1000.000. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-172-1054, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| special_features | ANHYDROUS |
| primary_container_type | BOTTLE |
| therapeutic_equivalent | SLO-BID BY RORER PHARMACEUTICALS |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| active_medicament_medicinal_strength | 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT |
| capsule_primary_container_content_quantity | 1000.000 |
| NSN | 6505-01-172-1054 |
| THERAPEUTIC EQUIVALENT | SLO-BID BY RORER PHARMACEUTICALS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE |
| SPECIAL FEATURES | ANHYDROUS |
| CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 1000.000 |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT |